FindTrial
Sign In

Application and Coomparison of PSMA-PET/CT and Multiparameter MRI in the Assessment of Prostate Cancer

Application and Coomparison of PSMA-PET/CT and Multiparameter MRI in the Assessment of Prostate Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090817
Enrollment
Unknown
Registered
2024-10-14
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Good pathological group/bad pathological group:none

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Radical prostatectomy for prostate cancer patients 2. Patients with preoperative MRI and PET-CT image data

Exclusion criteria

Exclusion criteria: 1. Patients who received neoadjuvant hormone therapy, preoperative radiotherapy, or neoadjuvant chemotherapy 2. Patients with incomplete important clinical data

Design outcomes

Primary

MeasureTime frame
pathological grading;Envelope invasion;vascular invasion;Incisal positive;PSA persistence;—

Countries

China

Contacts

Public ContactYunjun Yang

The First Affiliated Hospital of Wenzhou Medical University

yyjunjim@163.com+86 577 5557 8779

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026